ATE308540T1 - Antithrombosemittel - Google Patents

Antithrombosemittel

Info

Publication number
ATE308540T1
ATE308540T1 AT01961622T AT01961622T ATE308540T1 AT E308540 T1 ATE308540 T1 AT E308540T1 AT 01961622 T AT01961622 T AT 01961622T AT 01961622 T AT01961622 T AT 01961622T AT E308540 T1 ATE308540 T1 AT E308540T1
Authority
AT
Austria
Prior art keywords
antithrombotic agents
prodrug
compound
inhibitor
factor
Prior art date
Application number
AT01961622T
Other languages
English (en)
Inventor
Douglas Wade Beight
John Joseph Masters
Jason Scott Sawyer
Robert Theodore Shuman
Michael Robert Wiley
Ying Kwong Yee
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE308540T1 publication Critical patent/ATE308540T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT01961622T 2000-08-17 2001-08-06 Antithrombosemittel ATE308540T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22592600P 2000-08-17 2000-08-17
PCT/US2001/021130 WO2002014308A1 (en) 2000-08-17 2001-08-06 Antithrombotic agents

Publications (1)

Publication Number Publication Date
ATE308540T1 true ATE308540T1 (de) 2005-11-15

Family

ID=22846837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961622T ATE308540T1 (de) 2000-08-17 2001-08-06 Antithrombosemittel

Country Status (7)

Country Link
US (1) US6924296B2 (de)
EP (1) EP1311501B1 (de)
AT (1) ATE308540T1 (de)
AU (1) AU2001282871A1 (de)
DE (1) DE60114640T2 (de)
ES (1) ES2248380T3 (de)
WO (1) WO2002014308A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1379506A2 (de) 2000-11-28 2004-01-14 Eli Lilly And Company Substituierte carbonsäureamide
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US7449457B2 (en) 2001-12-07 2008-11-11 Eli Lilly And Company Substituted heterocyclic carboxamides with antithrombotic activity
KR20050118708A (ko) 2003-04-03 2005-12-19 메르크 파텐트 게엠베하 혈전-색전 질환의 치료에서 응고 인자 xa의 저해제로서사용하기 위한피롤리디노-1,2-디카르복시-1-(페닐아미드)-2-(4-(3-옥소-모르폴리노-4-일)-페닐아미드) 유도체 및 관련화합물
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
PL1966130T3 (pl) * 2005-12-23 2014-05-30 Zealand Pharma As Zmodyfikowane związki mimetyczne lizyny
JP2009523553A (ja) * 2006-01-17 2009-06-25 ゾゲニクス インコーポレーティッド 抗血栓薬の単回用量無針投与方法
EP2083816A2 (de) 2006-10-27 2009-08-05 Brystol-Myers Squibb Company Heterocyclische amidverbindungen als kinasehemmer
CN101239937B (zh) * 2007-02-07 2010-05-19 上海雅本化学有限公司 一种光学活性r-(-)-1-苄氧羰基-3-氨基吡咯烷及其盐酸盐的制备方法
EP1975165A1 (de) * 2007-03-27 2008-10-01 Boehringer Ingelheim Pharma GmbH & Co. KG Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
RU2643336C1 (ru) * 2016-10-03 2018-01-31 Общество с Ограниченной Ответственностью "Компания "ЭЛТА" СРЕДСТВО, ПРОЯВЛЯЮЩЕЕ АНТИТРОМБОТИЧЕСКИЙ ЭФФЕКТ ПОСРЕДСТВОМ БЛОКИРОВАНИЯ РЕЦЕПТОРОВ ТРОМБОЦИТОВ ГП IIb-IIIa (ВАРИАНТЫ)
LT3993876T (lt) 2019-07-01 2024-11-11 Tonix Pharma Limited Antikūnai prieš cd154 ir jų panaudojimas
CN116963750A (zh) 2021-01-06 2023-10-27 通尼克斯制药有限公司 用经修饰的抗-cd154抗体诱导免疫耐受的方法
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2248911T3 (es) 1997-06-26 2006-03-16 Eli Lilly And Company Agentes antitromboticos.
ES2241151T3 (es) 1997-06-26 2005-10-16 Eli Lilly And Company Agentes antitromboticos.
IL133625A0 (en) 1997-06-26 2001-04-30 Lilly Co Eli Antithrombotic agents
CA2294042A1 (en) 1997-06-26 1999-01-07 David Kent Herron Antithrombotic agents
WO2000039118A1 (en) 1998-12-23 2000-07-06 Eli Lilly And Company Aromatic amides
JP2004522689A (ja) 1998-12-23 2004-07-29 イーライ・リリー・アンド・カンパニー 抗血栓アミド類
ES2196917T3 (es) 1998-12-23 2003-12-16 Lilly Co Eli Amidas heteroaromaticas como inhibidores del factor xa`.
EP1140839B1 (de) 1998-12-24 2004-03-17 Eli Lilly And Company Heterocyclische amide als inhibitoren von faktor xa
DE60130771T2 (de) 2000-07-27 2008-07-17 Eli Lilly And Co., Indianapolis Substituierte heterocyclische amide

Also Published As

Publication number Publication date
DE60114640D1 (en) 2005-12-08
WO2002014308A1 (en) 2002-02-21
US20040010017A1 (en) 2004-01-15
DE60114640T2 (de) 2006-07-20
US6924296B2 (en) 2005-08-02
ES2248380T3 (es) 2006-03-16
AU2001282871A1 (en) 2002-02-25
EP1311501B1 (de) 2005-11-02
EP1311501A1 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
ATE306261T1 (de) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
DE69931393D1 (de) Antithrombotische amide
ATE272633T1 (de) Aromatische amiden
AU2001280438A1 (en) Substituted heterocyclic amides
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
CY1107634T1 (el) Φαρμακευτικη συνθεση
YU69902A (sh) Novi derivati piperazina
MXPA03005464A (es) Agentes antivirales.
ES2196917T3 (es) Amidas heteroaromaticas como inhibidores del factor xa`.
SE0302760D0 (sv) New compounds
DE602005016297D1 (de) Antithrombotische diamide
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
AU2364000A (en) Heterocyclic amides as inhibitors of factor xa
ATE308540T1 (de) Antithrombosemittel
NO20040881L (no) Orale antidiabetes midler.
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
WO2005049604A3 (en) Antithrombotic aromatic ethers
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
GB0212410D0 (en) Organic compounds
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
SE0102057D0 (sv) New Salts I
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
SE0102058D0 (sv) New Salts II
ATE382607T1 (de) Antitrombotische aether

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties